This proposed rule focuses primarily on PMTA assessment processes and information needs, specifically with respect to software acceptance and submitting. An application may well satisfy the acceptance and submitting prerequisites, but nonetheless deficiency critical information and facts that FDA wants to find out no matter if it must problem a adv